73 related articles for article (PubMed ID: 33914043)
1. High-risk Human Papillomavirus Testing for Cervical Cancer Screening-Reply.
Dang L; Qiao Y; Lang J
JAMA Oncol; 2021 Jul; 7(7):1067-1068. PubMed ID: 33914043
[No Abstract] [Full Text] [Related]
2. High-risk Human Papillomavirus Testing for Cervical Cancer Screening.
Totten SPS; Romero JM
JAMA Oncol; 2021 Jul; 7(7):1066-1067. PubMed ID: 33914042
[No Abstract] [Full Text] [Related]
3. Cervical Cancer Elimination Is Dependent on Women's Self-Tests for Primary Human Papillomavirus Testing Triaged by Methylation Status.
Harper DM
J Clin Oncol; 2022 Sep; 40(26):3003-3005. PubMed ID: 35594490
[No Abstract] [Full Text] [Related]
4. Re: Human papillomavirus testing in the prevention of cervical cancer.
Suba EJ; Michelow PM; Raab SS
J Natl Cancer Inst; 2011 Oct; 103(19):1482-3; author reply 1483-4. PubMed ID: 21859986
[No Abstract] [Full Text] [Related]
5. T Cell Receptor Repertoires Acquired
Christley S; Ostmeyer J; Quirk L; Zhang W; Sirak B; Giuliano AR; Zhang S; Monson N; Tiro J; Lucas E; Cowell LG
Front Immunol; 2021; 12():624230. PubMed ID: 33868241
[TBL] [Abstract][Full Text] [Related]
6. [Cervical cancer screening and the place of the HPV test in 2012].
Bosch FX; Bergeron C
Ann Pathol; 2012 Nov; 32(5 Suppl):S22-3. PubMed ID: 23127928
[No Abstract] [Full Text] [Related]
7. Cervical cancer screening by human papillomavirus testing followed by cytology triage--reply.
Feldman S
JAMA Intern Med; 2015 Jun; 175(6):1068-9. PubMed ID: 26030859
[No Abstract] [Full Text] [Related]
8. [Cervical cancer screening: restoration or reconstruction?].
Riethmuller D
Gynecol Obstet Fertil; 2009; 37(7-8):671-9. PubMed ID: 19577501
[No Abstract] [Full Text] [Related]
9. Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits.
Malone C; Tiro JA; Buist DS; Beatty T; Lin J; Kimbel K; Gao H; Thayer C; Miglioretti DL; Winer RL
J Med Screen; 2020 Sep; 27(3):146-156. PubMed ID: 31744374
[TBL] [Abstract][Full Text] [Related]
10. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines.
Almonte M; Sasieni P; Cuzick J
Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):617-29. PubMed ID: 21683657
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus testing for primary cervical cancer screening: is it time to abandon Papanicolaou testing?
Feldman S
JAMA Intern Med; 2014 Oct; 174(10):1539-40. PubMed ID: 25069413
[No Abstract] [Full Text] [Related]
12. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology.
Nishino HT; Tambouret RH; Wilbur DC
Cancer Cytopathol; 2011 Aug; 119(4):219-27. PubMed ID: 21717588
[TBL] [Abstract][Full Text] [Related]
13. Self-sampling for high-risk human papillomavirus detection: future cervical cancer screening?
Daponte A; Pournaras S; Tsakris A
Womens Health (Lond); 2014 Mar; 10(2):115-8. PubMed ID: 24601801
[No Abstract] [Full Text] [Related]
14. Cervical cancer screening leapfrog with human papilloma-virus testing.
Karas A
S Afr Med J; 2004 Jun; 94(6):395-6. PubMed ID: 15250438
[No Abstract] [Full Text] [Related]
15. [Cervical cancer screening: a new tool to do one's best or doing one's best with a new tool?].
Lavoué V; Levêque J
Gynecol Obstet Fertil; 2009; 37(7-8):680-2. PubMed ID: 19574078
[No Abstract] [Full Text] [Related]
16. Ensuring quality in cervical screening programmes based on molecular human papillomavirus testing.
Cuschieri K; Schuurman R; Coughlan S
Cytopathology; 2019 May; 30(3):273-280. PubMed ID: 30657615
[TBL] [Abstract][Full Text] [Related]
17. Re: Preventing cervical cancer globally by acting locally: if not now, when?
Suba EJ; Michelow PM; Wright CA; Raab SS
J Natl Cancer Inst; 2011 Apr; 103(7):611-2; author reply 612-3. PubMed ID: 21451154
[No Abstract] [Full Text] [Related]
18. Cervical Cancer Screening with Human Papillomavirus Self-Sampling Among Transgender Men in El Salvador.
Maza M; Meléndez M; Herrera A; Hernández X; Rodríguez B; Soler M; Alfaro K; Masch R; Conzuelo-Rodríguez G; Obedin-Maliver J; Cremer M
LGBT Health; 2020; 7(4):174-181. PubMed ID: 32407149
[No Abstract] [Full Text] [Related]
19. Cervical cancer screening by human papillomavirus testing followed by cytology triage.
Giorgi-Rossi P; Arbyn M; Meijer CJ
JAMA Intern Med; 2015 Jun; 175(6):1068. PubMed ID: 26030858
[No Abstract] [Full Text] [Related]
20. [High-risk human papilloma virus DNA detection kit (cervista HPV HR) should be highly validated clinically in cervical cancer screening programs].
Zhao J; Zhang XG; Chen R; Bi H; Wang X; Liu GW; Yao DX; Zong Y; Liao QP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):149-51. PubMed ID: 21863645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
